Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,806.00    46.00 (1.22%)
Bid:
3,804.00
Ask:
3,812.00
Spread: 8.00 (0.21%)
Market Cap: £1.07b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

27 Oct 2008 07:00

RNS Number : 6716G
4imprint Group PLC
27 October 2008
 



4imprint Group plc 

Interim Management Statement

The Board of 4imprint Group plc today issues its interim management statement for the period from 29 June 2008 to 27 September 2008

Group sales in Q3 at £42.4m were 20% ahead of the same period last year, and cumulative sales for the 9 months, at £120.5m, were 15% ahead. Seasonally, the third quarter is less strong than the second quarter.

In the Divisions, the Direct Marketing Division achieved Q3 sales in sterling of £25.6m, 30% ahead of last year and £68.6m for the 9 months, 24% ahead. 

The End User Division achieved Q3 sales of £12.7m, 13% ahead of last 

year, and £39.0for the 9 months, 15% ahead. 

Trade Division sales for Q3, at £4.1m, were 9% down on the same period 

last year, while for the 9 months sales were £12.9m, 15lower. Total sales, including inter divisional sales were £15.2m, 18% lower. 

Unaudited cumulative Q3 Group operating profit before defined benefit pension costs, share option charges and exceptional costs was £7.0m, 3% ahead of last year. 

Trading conditions generally in the main markets served by the Group, notably North America and the UK, remain uncertain and the Group continues to take appropriate initiatives to mitigate these conditions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSBDGGSDGGIS
Date   Source Headline
16th Oct 201711:13 amRNSEBT purchase
9th Oct 20172:25 pmRNSEBT purchase
22nd Sep 20172:12 pmRNSEBT Purchase
20th Sep 20174:06 pmRNSHolding(s) in Company
13th Sep 20173:24 pmRNSHolding(s) in Company
17th Aug 20178:59 amRNSHolding(s) in Company
3rd Aug 20179:06 amRNSDirector/PDMR Shareholding
1st Aug 20174:41 pmRNSSecond Price Monitoring Extn
1st Aug 20174:35 pmRNSPrice Monitoring Extension
1st Aug 20177:00 amRNSHalf-year Report
4th Jul 20172:58 pmRNSHolding(s) in Company
28th Jun 201710:18 amRNSHolding(s) in Company
22nd Jun 20173:11 pmRNSHolding(s) in Company
20th Jun 20179:29 amRNSNotice of Results
16th May 20179:30 amRNSHolding(s) in Company
11th May 20172:57 pmRNSEBT Purchase
11th May 20178:38 amRNSDirector/PDMR Shareholding
10th May 20174:30 pmRNSDirector/PDMR Shareholding
10th May 20172:25 pmRNSHolding(s) in Company
10th May 201712:06 pmRNSResult of AGM
9th May 20174:02 pmRNSHolding(s) in Company
9th May 20177:00 amRNSAGM Trading Statement
8th May 20179:38 amRNSHolding(s) in Company
4th Apr 20173:52 pmRNSAnnual Financial Report
30th Mar 20179:12 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSFinal Results
19th Jan 20177:00 amRNSTrading Update and Notice of Final Results
9th Dec 20164:35 pmRNSPrice Monitoring Extension
8th Dec 20164:12 pmRNSEBT Purchase
28th Nov 201612:01 pmRNSEBT Purchase
22nd Nov 201611:03 amRNSEBT Purchase
9th Nov 201612:07 pmRNSSecond Price Monitoring Extn
9th Nov 201612:02 pmRNSPrice Monitoring Extension
2nd Nov 20167:00 amRNSTrading Update
7th Oct 20169:27 amRNSHolding(s) in Company
3rd Oct 20168:43 amRNSHolding(s) in Company
12th Aug 20168:53 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSDirectorate Change
10th Aug 201611:10 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSHalf-year Report
16th Jun 20169:26 amRNSNotice of Results
19th May 20169:46 amRNSHolding(s) in Company
10th May 20164:39 pmRNSResult of AGM
10th May 201611:00 amRNSAGM Statement
9th May 201610:15 amRNSHolding(s) in Company
5th May 20168:33 amRNSHolding(s) in Company
3rd May 20168:38 amRNSTotal Voting Rights
25th Apr 20161:13 pmRNSHolding(s) in Company
19th Apr 201610:00 amRNSDirector/PDMR Shareholding
14th Apr 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.